Editorial
Volume 12 Issue 4 - 2020
Cognitive Impairment as a Biomarker in Multiple Sclerosis
Grigorios Nasios1* and Lambros Messinis2
1Department of Speech and Language Therapy, School of Health Sciences, University of Ioannina, Ioannina, Greece
2Neuropsychology Section, Departments of Neurology and Psychiatry, University of Patras Medical School, Patras, Greece
*Corresponding Author: Grigorios Nasios, Department of Speech and Language Therapy, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Received: February 27, 2020; Published: March 09, 2020




Although Multiple Sclerosis (MS) is a single disease entity, no one person living with MS (pwMS) has the same clinical profile with another. The classical pathoanatomical study of Lucchinetti., et al. [1], classifies the disease into four subtypes based on material from biopsies and autopsies of patient’s brains. Neuroimaging studies on the other hand have identified four different subtypes based on the relationship between brain lesions and atrophy [2].

On a clinical level the diversity of motor, sensory, cognitive and psychological symptoms and signs and the wide range of severity may lead to an accumulation of disabilities, which in general accumulate within the decades of the disease course, but some patients present these disabilities earlier in the course of the disease and with more severe disability and others much later on and with less severe disability. Some patients may even present with a largely debated condition known as “benign” MS. In this disease course patients experience little disease progression and minimal accumulation of disability decades after developing the disease.

References

  1. Lucchinetti C., et al. “Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination”. Annals of Neurology 47.6 (2000): 707-717. 
  2. Tauhid S., et al. “MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis”. Journal of the Neurological Sciences 346.1-2 (2014): 250-254. 
  3. Sayao AL., et al. “The psychosocial and cognitive impact of longstanding “benign” multiple sclerosis”. Multiple Sclerosis Journal 17.11 (2011): 1375-1383. 
  4. Menon S., et al. “Characterising aggressive multiple sclerosis”. Journal of Neurology, Neurosurgery, and Psychiatry 84.11 (2013): 1192-1198. 
  5. Harel Y., et al. “Cognitive function in multiple sclerosis: A long-term look on the bright side”. PLoS One 14.8 (2019): e0221784. 
  6. Chitnis T and Prat A. “A roadmap to precision medicine for multiple sclerosis”. Multiple Sclerosis Journal 22 (2020): 1352458519881558. 
  7. Messinis L., et al. “Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation: Editorial”. Behavioural Neurology (2018). 
  8. Messinis L., et al. “Neuropsychological Functions and Cognitive Neurorehabilitation in Multiple Sclerosis”. IntechOpen (2019). 
  9. Cortese M., et al. “Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom”. Annals of Neurology 80.4 (2016): 616-624. 
  10. Ruggieri RM., et al. “Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS ≤ 3.5”. Acta Neurologica Scandinavica 108 (2003): 323-326. 
  11. Messinis L., et al. “Cognitive deficits in relapsing remitting multiple sclerosis patients with low disability status”. In: Proceedings of the 7th International Congress on the Improvement of the Quality of life on Dementia, Parkinson’s disease, Epilepsy, MS, Muscular Disorders and Neuroethics (2009): 31-35. 
  12. Romero K., et al. “Neurologists׳ accuracy in predicting cognitive impairment in multiple sclerosis”. Multiple Sclerosis and Related Disorders 4.4 (2015): 291-295. 
  13. Bakirtzis C., et al. “The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians”. The Open Neurology Journal 31.12 (2018): 31-40. 
  14. Nasios G., et al. “Cognitive impairment and brain reorganization in MS: underlying mechanisms and the role of neurorehabilitation”. Frontiers in Neurology (2020).
Citation: Grigorios Nasios and Lambros Messinis. “Cognitive Impairment as a Biomarker in Multiple Sclerosis”. EC Neurology 12.4 (2020): 01-03.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for September Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the September issue of respective journals. Submissions are accepted on/before August 15, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk